Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for type 1 corticotropin- releasing hormone receptor
Most Correlated Studies
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Most Relevant Literature
- Discovery of a stable tripeptide targeting the N-domain of CRF1 receptor.
- Both CRF1 and CRF2 receptors in the bed nucleus of stria terminalis are involved in baroreflex impai…
- Sex-linked roles of the CRF1 and the CRF2 receptor in social behavior.
- Anxiogenesis induced by social defeat in male mice: Role of nitric oxide, NMDA, and CRF1 receptors i…
- Role of CRF1 receptor in post-incisional plasma extravasation and nociceptive responses in mice.
Most Relevant Clinical Trials
- Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^
- Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1
- Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers
- Effect of CRH on Duodenal Markers and Gastric Sensorimotor Function
- A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis
